Condition

Metastatic Breast Cancer (MBC)

ClinicalTrials.gov condition label

Clinical trials8
Recruiting2
Common interventions22
Lead sponsors shown6

Clinical trials

8 shown
A Study of Romosozumab in People With Breast Cancer and OsteoporosisNCT07776613 · 2026-08-17
RECRUITING
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer PatientsNCT06833853 · 2026-03-13
RECRUITING
Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer PatientsNCT07840599 · 2027-01-01
NOT_YET_RECRUITING
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast CancerNCT06143553 · 2023-09-25
UNKNOWN
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)NCT02605486 · 2015-11-11
ACTIVE_NOT_RECRUITING
A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabNCT01471847 · 2012-02-01
COMPLETED
Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast CancerNCT01495247 · 2012-01-30
TERMINATED
Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBCNCT00236899 · 2005-09-01
COMPLETED

Common interventions

PaclitaxelDRUG2BEZ235DRUG1BEZ235 + Trastuzumab Phase l/Phase ll)DRUG1Bi-Weekly CoachingBEHAVIORAL1BicalutamideDRUG1Capecitabine TabletsDRUG1Core InterventionBEHAVIORAL1DocetaxelDRUG1EHR Integration (On v. Off)BEHAVIORAL1Eribulin Mesilate injectionDRUG1GemcitabineDRUG1Gemcitabine Hydrochloride for InjectionDRUG1Highly Tailored Goal SettingBEHAVIORAL1Lapatinib + Capecitabine (Phase II)DRUG1Paclitaxel (albumin-bound)DRUG1Paclitaxel Polymeric Micelles for InjectionDRUG1PalbociclibDRUG1RomosozumabDRUG1Social+ (on v. off)BEHAVIORAL1Static Goal SettingBEHAVIORAL1Vinorelbine Tartrate InjectionDRUG1Weekly CoachingBEHAVIORAL1

Trial status mix

COMPLETED2
RECRUITING2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
TERMINATED1
UNKNOWN1

Phase mix

PHASE13
PHASE23
PHASE32
NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.